We are live on ! Find out more
SBRA icon

Sabra Healthcare REIT

359 hedge funds and large institutions have $3.03B invested in Sabra Healthcare REIT in 2023 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 120 increasing their positions, 103 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

329% more call options, than puts

Call options by funds: $3.75M | Put options by funds: $873K

97% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 35

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

17% more repeat investments, than reductions

Existing positions increased: 120 | Existing positions reduced: 103

9% more funds holding

Funds holding: 329359 (+30)

2% more capital invested

Capital invested by funds: $2.96B → $3.03B (+$71.2M)

0.04% more ownership

Funds ownership: 91.78%91.83% (+0.04%)

Holders
359
Holders Change
+30
Holders Change %
+9.12%
% of All Funds
5.23%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
69
Increased
120
Reduced
103
Closed
35
Calls
$3.75M
Puts
$873K
Net Calls
+$2.87M
Net Calls Change
+$1.61M
Name Holding Trade Value Shares
Change
Change in
Stake
CIM
201
Cambria Investment Management
California
$344K
KAS
202
Kestra Advisory Services
Texas
$328K +$326K +22,971 New
Creative Planning
203
Creative Planning
Kansas
$327K -$14.2K -999 -4%
ECM
204
EMC Capital Management
Texas
$322K
VPIM
205
Vanguard Personalized Indexing Management
California
$319K -$10.7K -753 -3%
Natixis Advisors
206
Natixis Advisors
Massachusetts
$317K +$24.1K +1,696 +8%
Toronto Dominion Bank
207
Toronto Dominion Bank
Ontario, Canada
$315K -$46.8K -3,293 -13%
PPW
208
Pasadena Private Wealth
California
$305K +$303K +21,351 New
Cambridge Investment Research Advisors
209
Cambridge Investment Research Advisors
Iowa
$303K -$141K -9,908 -32%
SOW
210
State of Wyoming
Wyoming
$301K +$299K +21,086 New
HEIP
211
Hudson Edge Investment Partners
New Jersey
$300K -$5.11K -360 -2%
US Bancorp
212
US Bancorp
Minnesota
$295K +$22.7K +1,596 +8%
FHB
213
First Hawaiian Bank
Hawaii
$295K -$41K -2,890 -12%
ECM
214
Endurant Capital Management
California
$286K -$2.61M -183,775 -90%
MLICM
215
Metropolitan Life Insurance Company (MetLife)
New York
$284K -$7.31K -515 -3%
USAA
216
United Services Automobile Association
Texas
$281K
SAM
217
Securian Asset Management
Minnesota
$278K -$1.42K -100 -0.5%
Squarepoint
218
Squarepoint
New York
$274K +$272K +19,188 New
A
219
AlphaQuest
New York
$274K +$272K +19,185 New
Focus Partners Wealth
220
Focus Partners Wealth
Massachusetts
$273K +$271K +19,110 New
CFGS
221
Concourse Financial Group Securities
Alabama
$269K -$190K -13,388 -42%
AA
222
ALPS Advisors
Colorado
$264K -$17.8K -1,255 -6%
GRP
223
Global Retirement Partners
California
$260K +$8.34K +587 +3%
AIA
224
Affinity Investment Advisors
California
$255K -$207K -14,561 -45%
PA
225
Parallel Advisors
California
$252K +$12.9K +906 +5%

SBRA Hedge Fund Activity: Q4 2023 in Review

359 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Sabra Healthcare REIT (SBRA) for Q4 2023, worth a combined $3.03B — up 2.4% from $2.96B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new SBRA positions and 35 closed out — a net gain of 34 holders — while 120 added to existing stakes and 103 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $48.8M. The largest seller was JP Morgan Chase, cutting an estimated $96.5M.

  • 359 institutional investors held Sabra Healthcare REIT (SBRA) as of Q4 2023, up from 329 in Q3 2023.
  • Funds reported $3.03B of Sabra Healthcare REIT stock for Q4 2023, up 2.4% quarter-over-quarter.
  • 69 funds opened new Sabra Healthcare REIT positions in Q4 2023 and 35 closed out, a net change of +34 holders.
  • The largest Sabra Healthcare REIT buyer in Q4 2023 was Deutsche Bank, an estimated $48.8M added.
  • The largest Sabra Healthcare REIT seller in Q4 2023 was JP Morgan Chase, an estimated $96.5M sold.

Based on aggregated 13F filings for Q4 2023.